Regulation of rbST in the US

Robert Collier

    Research output: Contribution to journalReview articlepeer-review

    11 Scopus citations


    In the United States (US) and European Union (EU) the regulatory and commercialization process for recombinant bovine somatotropin (rbST) had widely differing outcomes. Although the regulatory process in both locations was completed in 1993 the commercialization of rbST in the US has been highly successful while completely failing in the EU. This paper examines these events from the US perspective and concludes that reasons for the difference in commercial success lie in the cultural, regulatory, and political background differences between the two world locations.

    Original languageEnglish (US)
    Pages (from-to)156-163
    Number of pages8
    Issue number2-3
    StatePublished - 2000


    • Dairy cattle
    • Public acceptance
    • Regulatory process
    • Somatotropin

    ASJC Scopus subject areas

    • Biotechnology
    • Food Science
    • Agronomy and Crop Science
    • Economics and Econometrics


    Dive into the research topics of 'Regulation of rbST in the US'. Together they form a unique fingerprint.

    Cite this